Industry Newsmedical aiacute deterioration detectionrespireeregulatory approval
Respiree Secures HSA Approval For 1BioAI Software
5.0
Respiree, an AI/ML health-tech startup, received Health Sciences Authority (HSA) approval in Singapore on Dec. 8, 2025 for its AI-enabled 1BioAI software to support acute deterioration detection in clinical settings.
Key Points
- 1Approves Respiree's 1BioAI software for acute deterioration detection in Singapore (HSA approval).
- 2Likely validates safety and performance claims, enabling market access and clinician adoption in Singapore.
- 3May indicate pathway for further regulatory approvals and commercialization in regional healthcare markets.
Scoring Rationale
Official HSA approval signals meaningful commercial validation, but RSS-only source and limited metadata reduce confidence in full details.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
Used by DS/ML engineers at top companies
250 free problems · No credit card
See all Health & Insurance problems
